In the present study we analyzed the therapeutic potential of two EC/EV drugs, JWH-133 (a potent CB2 selective agonist) and RTX (an analog of capsaicin, a vanilloid agonist), in primary cell cultures obtained from 4 patients affected with T-ALL and in Jurkat cell line. The gene discussed is CNR2; the disease is acute lymphoblastic leukemia.